{"id":262229,"date":"2026-09-22T15:23:21","date_gmt":"2026-09-22T09:53:21","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=262229"},"modified":"2026-09-22T15:23:21","modified_gmt":"2026-09-22T09:53:21","slug":"why-jenburkt-pharmaceuticals-ltd-share-price-near-52-week-low-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-jenburkt-pharmaceuticals-ltd-share-price-near-52-week-low-today-2026\/","title":{"rendered":"Jenburkt Pharmaceuticals Ltd. (JENBURPH): Jenburkt Pharmaceuticals Share Price near 52-week low after 3.15% fall"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/jenburph\/jenburkt-pharmaceuticals-ltd-share-price-today\">Jenburkt Pharmaceuticals Ltd. (JENBURPH)<\/a> share price is trading within 2% of its 52-week low of Rs 950 today and later stood at Rs 956, down 3.15% from the previous close. Market cap was Rs 435.64 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;\">Jenburkt Pharmaceuticals Share Price is under pressure today, with the stock at Rs 956 after falling 3.15% from the previous close. The move keeps the counter near its 52-week low zone, while market capitalisation stands at Rs 435.64 crore. Jenburkt Pharmaceuticals Ltd. (JENBURPH) is drawing attention in stock news because the latest price action confirms renewed weakness, but the supplied data does not establish a company-specific catalyst. For readers tracking Jenburkt Pharmaceuticals Share Price Today, the key question is whether this is only a short-term price swing or part of a broader trend. Univest\u2019s data points to a clear decline, a modest turnover reading and a valuation profile that still needs to be weighed against healthcare peers.<\/p>\n<p>That makes Jenburkt Pharmaceuticals Share Price relevant for both traders and long-term investors who follow 52-week low stocks, support levels and market update coverage. The stock\u2019s technical posture is not being framed by a full indicator set here, but the price remains well below key moving averages and below its previous close. The result is a stock news event that invites closer fundamental analysis rather than a quick conclusion.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-jenburkt-pharmaceuticals-ltd-share-price-near-52-week-low-today-2026\/#Jenburkt_Pharmaceuticals_Share_Price_Today_Price_Action_Analysis\" title=\"Jenburkt Pharmaceuticals Share Price Today: Price Action Analysis\">Jenburkt Pharmaceuticals Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-jenburkt-pharmaceuticals-ltd-share-price-near-52-week-low-today-2026\/#Jenburkt_Pharmaceuticals_Ltd_JENBURPH_Fundamental_Analysis\" title=\"Jenburkt Pharmaceuticals Ltd. (JENBURPH) Fundamental Analysis\">Jenburkt Pharmaceuticals Ltd. (JENBURPH) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-jenburkt-pharmaceuticals-ltd-share-price-near-52-week-low-today-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-jenburkt-pharmaceuticals-ltd-share-price-near-52-week-low-today-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-jenburkt-pharmaceuticals-ltd-share-price-near-52-week-low-today-2026\/#Why_Investors_Are_Watching_Jenburkt_Pharmaceuticals\" title=\"Why Investors Are Watching Jenburkt Pharmaceuticals\">Why Investors Are Watching Jenburkt Pharmaceuticals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-jenburkt-pharmaceuticals-ltd-share-price-near-52-week-low-today-2026\/#About_Jenburkt_Pharmaceuticals_Ltd\" title=\"About Jenburkt Pharmaceuticals Ltd.\">About Jenburkt Pharmaceuticals Ltd.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-jenburkt-pharmaceuticals-ltd-share-price-near-52-week-low-today-2026\/#Track_Jenburkt_Pharmaceuticals_Share_Price_on_Univest\" title=\"Track Jenburkt Pharmaceuticals Share Price on Univest\">Track Jenburkt Pharmaceuticals Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-jenburkt-pharmaceuticals-ltd-share-price-near-52-week-low-today-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-jenburkt-pharmaceuticals-ltd-share-price-near-52-week-low-today-2026\/#Why_is_Jenburkt_Pharmaceuticals_Share_Price_falling_today\" title=\"Why is Jenburkt Pharmaceuticals Share Price falling today?\">Why is Jenburkt Pharmaceuticals Share Price falling today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-jenburkt-pharmaceuticals-ltd-share-price-near-52-week-low-today-2026\/#What_is_Jenburkt_Pharmaceuticals_Share_Price_today\" title=\"What is Jenburkt Pharmaceuticals Share Price today?\">What is Jenburkt Pharmaceuticals Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-jenburkt-pharmaceuticals-ltd-share-price-near-52-week-low-today-2026\/#Is_Jenburkt_Pharmaceuticals_close_to_a_52-week_low\" title=\"Is Jenburkt Pharmaceuticals close to a 52-week low?\">Is Jenburkt Pharmaceuticals close to a 52-week low?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-jenburkt-pharmaceuticals-ltd-share-price-near-52-week-low-today-2026\/#What_is_Jenburkt_Pharmaceuticals_market_cap\" title=\"What is Jenburkt Pharmaceuticals market cap?\">What is Jenburkt Pharmaceuticals market cap?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-jenburkt-pharmaceuticals-ltd-share-price-near-52-week-low-today-2026\/#What_do_the_valuation_metrics_show_for_Jenburkt_Pharmaceuticals_Share_Price\" title=\"What do the valuation metrics show for Jenburkt Pharmaceuticals Share Price?\">What do the valuation metrics show for Jenburkt Pharmaceuticals Share Price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-jenburkt-pharmaceuticals-ltd-share-price-near-52-week-low-today-2026\/#How_does_Jenburkt_Pharmaceuticals_compare_with_healthcare_peers\" title=\"How does Jenburkt Pharmaceuticals compare with healthcare peers?\">How does Jenburkt Pharmaceuticals compare with healthcare peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-jenburkt-pharmaceuticals-ltd-share-price-near-52-week-low-today-2026\/#Where_can_I_track_Jenburkt_Pharmaceuticals_Share_Price_and_stock_news\" title=\"Where can I track Jenburkt Pharmaceuticals Share Price and stock news?\">Where can I track Jenburkt Pharmaceuticals Share Price and stock news?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Jenburkt_Pharmaceuticals_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Jenburkt Pharmaceuticals Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 956<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 987.1<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs -31.1 (-3.15%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 997.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,000<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 950<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 0.14 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 435.64 crore<\/td>\n<\/tr>\n<\/table>\n<p>Jenburkt Pharmaceuticals Ltd. (JENBURPH) traded at Rs 956 versus the previous close of Rs 987.1, a fall of 3.15%. The stock opened at Rs 997.7, reached a high of Rs 1,000, touched a low of Rs 950.<\/p>\n<p>Jenburkt Pharmaceuticals Share Price Today shows a clear gap between opening trade and closing weakness. The stock opened at Rs 997.7, touched an intraday high of Rs 1,000 and a low of Rs 950 before settling at Rs 956. That leaves it Rs 31.1 below the previous close of Rs 987.1, a decline of 3.15% on the session.<\/p>\n<p>The day\u2019s price action suggests sustained selling pressure after the open, even though the stock briefly tested Rs 1,000. Turnover stood at Rs 0.14 crore, while market capitalisation remained Rs 435.64 crore. Because the stock is trading close to its 52-week low, the move matters for anyone tracking Jenburkt Pharmaceuticals Share Price Live, Jenburkt Pharmaceuticals Share News or broader stocks in news coverage on the Indian stock market. The session confirms weakness, but the supplied data does not establish a company-specific trigger. For that reason, investors watching Jenburkt Pharmaceuticals Stock News will likely focus next on whether the price can stabilise above nearby support and whether market news shifts the short-term price action.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Jenburkt_Pharmaceuticals_Ltd_JENBURPH_Fundamental_Analysis\"><\/span><strong>Jenburkt Pharmaceuticals Ltd. (JENBURPH) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 435.64 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.27x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.15x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">18.84%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">25.34%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 74.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 459.8<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.1%<\/td>\n<\/tr>\n<\/table>\n<p>Jenburkt Pharmaceuticals Ltd. (JENBURPH) fundamental metrics show P\/E 13.27x, P\/B 2.15x, ROE 18.84%, ROCE 25.34%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Jenburkt Pharmaceuticals Ltd. has a market capitalisation of Rs 435.64 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 13.27x, P\/B at 2.15x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.84% and ROCE of 25.34%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 74.39, book value per share of Rs 459.8, dividend yield of 2.1%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P\/E of 28.58x, median ROE of 11.7%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.27x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">28.58x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">41.98x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 747.32x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.15x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">18.84%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.7%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">25.34%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.61%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 435.64 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 762.92 crore<\/td>\n<\/tr>\n<\/table>\n<p>Jenburkt Pharmaceuticals Ltd. (JENBURPH) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Jenburkt Pharmaceuticals Ltd. (JENBURPH) has a P\/E ratio of 13.27x, which is below the benchmark median of 28.58x, a difference of -53.57%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Jenburkt Pharmaceuticals Ltd. (JENBURPH) has a ROE of 18.84%, which is above the benchmark median of 11.7%, a difference of +61.03%. Jenburkt Pharmaceuticals Ltd. (JENBURPH) has a ROCE of 25.34%, which is above the benchmark median of 13.61%, a difference of +86.19%.<\/p>\n<p>Track stocks falling to yearly lows through the <a href=\"https:\/\/univest.in\/screeners\/52-week-low\">Univest 52-week-low screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/haleoslabs\/sms-lifesciences-india-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>SMS Lifesciences India Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">HALEOSLABS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">447.49<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">28.08<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.06<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.03<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.6<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/medicameq\/medicamen-biotech-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Medicamen Biotech Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">MEDICAMEQ<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">447.91<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">39.38<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1.58<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.23<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.77<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/albertdavd\/albert-david-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Albert David Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ALBERTDAVD<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">479.4<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.25<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1.13<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-0.38<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0.83<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/tll\/trident-lifeline-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Trident Lifeline Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TLL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">376.71<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">23.15<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.47<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.78<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.17<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/astonealab\/astonea-labs-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Astonea Labs Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ASTONEALAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">372.61<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">80.2<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.34<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.95<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.51<\/td>\n<\/tr>\n<\/table>\n<p>Jenburkt Pharmaceuticals Ltd. (JENBURPH) has a P\/E ratio of 13.27x compared with the displayed peer median of 28.08x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.84% compares with a peer median of 10.03% across the companies shown in the table. ROCE stood at 25.34% versus the displayed peer median of 10.51%, providing a capital-efficiency comparison. Jenburkt Pharmaceuticals Ltd. (JENBURPH) has a market capitalisation of Rs 435.64 crore. Among the 5 peers shown, 3 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Jenburkt_Pharmaceuticals\"><\/span><strong>Why Investors Are Watching Jenburkt Pharmaceuticals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>The stock is trading near its 52-week low, so price action is central to the current Jenburkt Pharmaceuticals Share Price story.<\/li>\n<li>Session weakness was clear at Rs 956, with the stock below the previous close and below its 50 DMA of Rs 1,032.56 and 200 DMA of Rs 1,068.02.<\/li>\n<li>Fundamentals remain notable, with P\/E at 13.27, ROE at 18.84% and ROCE at 25.34%.<\/li>\n<li>The company\u2019s market cap of Rs 435.64 crore keeps it in the small-cap bucket, where sentiment can shift quickly.<\/li>\n<li>Healthcare sector comparisons show valuation below the benchmark median, while profitability stays above it.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Jenburkt_Pharmaceuticals_Ltd\"><\/span><strong>About Jenburkt Pharmaceuticals Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Jenburkt Pharmaceuticals Ltd. operates in the Pharmaceuticals &amp; Drugs industry within the Healthcare sector. The supplied data positions it as a small-cap listed company with a market capitalisation of Rs 435.64 crore. Its financial profile indicates meaningful earnings per share of Rs 74.39, book value per share of Rs 459.8 and a dividend yield of 2.1%, which helps frame the company\u2019s operating and valuation profile.<\/p>\n<p>From a company overview perspective, the available data points to a business that is being tracked for its earnings quality and capital efficiency rather than for sheer size. Revenue and net-profit history in the supplied financial series shows quarterly movement across recent periods, with revenue at Rs 355.12 crore in Jun 26 and net profit at Rs 58.85 crore in the same period. Those numbers give context to Jenburkt Pharmaceuticals Share Price, especially when investors compare company financials with price behaviour near a yearly low. For stock market readers, Jenburkt Pharmaceuticals Stock News remains tied to both its operating record and how the market values that record.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Jenburkt_Pharmaceuticals_Share_Price_on_Univest\"><\/span><strong>Track Jenburkt Pharmaceuticals Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/jenburph\/jenburkt-pharmaceuticals-ltd-share-price-today\">Jenburkt Pharmaceuticals Ltd. (JENBURPH) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-low\">Univest 52-week-low screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-low lists and related market analysis.<\/p>\n<p>Investors can track Jenburkt Pharmaceuticals Share Price on Univest for live share price updates, fundamental ratios, shareholding pattern views, 52-week levels, market insights and stock analysis. Univest also brings together technical indicators, valuation snapshots and sector context so readers can follow Jenburkt Pharmaceuticals Share Price Today with a cleaner research view. If you are scanning Jenburkt Pharmaceuticals Share Price Live, the platform helps connect price action, fundamentals and market cap in one place without forcing a recommendation.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Jenburkt_Pharmaceuticals_Share_Price_falling_today\"><\/span><strong>Why is Jenburkt Pharmaceuticals Share Price falling today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Jenburkt Pharmaceuticals Share Price fell 3.15% to Rs 956 from Rs 987.1. The data confirms the price event, but it does not establish a company-specific catalyst behind the move. The stock moved -3.15% during the session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Jenburkt_Pharmaceuticals_Share_Price_today\"><\/span><strong>What is Jenburkt Pharmaceuticals Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Jenburkt Pharmaceuticals Share Price today is Rs 956. It opened at Rs 997.7, moved between Rs 950 and Rs 1,000, and ended below the previous close of Rs 987.1. The stock moved -3.15% during the session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Jenburkt_Pharmaceuticals_close_to_a_52-week_low\"><\/span><strong>Is Jenburkt Pharmaceuticals close to a 52-week low?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes, Jenburkt Pharmaceuticals Share Price is trading near its 52-week low zone. That is why the stock is drawing attention in 52 Week Low Stocks and Stocks at 52 Week Low searches.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Jenburkt_Pharmaceuticals_market_cap\"><\/span><strong>What is Jenburkt Pharmaceuticals market cap?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Jenburkt Pharmaceuticals has a market capitalisation of Rs 435.64 crore. That places it in the small-cap category, where stock price moves can be sharper and sentiment often changes quickly. The company operates in the Healthcare sector.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_the_valuation_metrics_show_for_Jenburkt_Pharmaceuticals_Share_Price\"><\/span><strong>What do the valuation metrics show for Jenburkt Pharmaceuticals Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Jenburkt Pharmaceuticals trades at a P\/E of 13.27 and a P\/B of 2.15. Those levels sit below the industry median in the supplied healthcare benchmark, which supports a lower valuation reading.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Jenburkt_Pharmaceuticals_compare_with_healthcare_peers\"><\/span><strong>How does Jenburkt Pharmaceuticals compare with healthcare peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Jenburkt Pharmaceuticals Share Price sits alongside peers with higher P\/E multiples such as Medicamen Biotech and Astonea Labs. Its profitability ratios are competitive, especially versus several benchmark companies. Comparable listed companies include SMS Lifesciences India Ltd., Medicamen Biotech Ltd., Albert.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_track_Jenburkt_Pharmaceuticals_Share_Price_and_stock_news\"><\/span><strong>Where can I track Jenburkt Pharmaceuticals Share Price and stock news?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> You can track Jenburkt Pharmaceuticals Share Price on Univest for live price updates, technical indicators, fundamental ratios, shareholding pattern views and healthcare sector context in one place. The stock moved -3.15% during the session.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Jenburkt Pharmaceuticals Ltd. Share Price trades near its 52-week low at Rs 956, marking a 3.15% decline today. Market cap stands at Rs 435.64 crore.<\/p>\n","protected":false},"author":29,"featured_media":262228,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-262229","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["262228"],"rank_math_title":["Jenburkt Pharmaceuticals Share Price Today: price action"],"rank_math_description":["Jenburkt Pharmaceuticals Share Price stays near its yearly low as the stock falls 3.15%. Check price action, fundamentals and sector comparison."],"rank_math_focus_keyword":["Jenburkt Pharmaceuticals Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/Jenburkt_Pharmaceuticals_Ltd_JENBURPH_Jenburkt_Pharmaceuticals_Share_Price_near_52_week_low_after_315_fall_bearish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/262229","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=262229"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/262229\/revisions"}],"predecessor-version":[{"id":262230,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/262229\/revisions\/262230"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/262228"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=262229"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=262229"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=262229"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}